a Mycoplasma pneumoniae infection(passive) triggered byDiagnosis Macrophage activation syndrome
disseminated tuberculosis with tuberculous gumma in a patient with adult - onset(passive) triggered byYokozeki H. Macrophage activation syndrome
macrophage more Can systemic inflammatory response syndrome in a 5 year old with juvenile rheumatoid arthritiscausemacrophage activation syndrome
the activation and uncontrolled proliferation of T lymphocytes and well - differentiated macrophages , leading to widespread hemophagocytosis and cytokine overproduction(passive) to be caused byMacrophage activation syndrome
canakinumab in a patient with adult - onset Still 's disease(passive) triggered byReactive macrophage activation syndrome
refractory Kawasaki disease in an infant by Lind - Holst , Marie and Hartling , Ulla Birgitte and Christensen(passive) caused bymacrophage activation syndrome
paroxetine in a cancer patient | Palliative & Supportive Care | Cambridge Core Activation syndrome caused by p(passive) caused byActivation syndrome
Implications for Israel David Tanne MD 569 - 570 Abstract Full article Autoimmune / inflammatory syndromeleadingto macrophage activation syndrome
paroxetine in a cancer patient Tomomi Nishida , Makoto Wada , Mei Wada , Hiroshi Ito , Masaru Narabayashi(passive) caused byActivation syndrome
an excessive activation and proliferation of mature macrophages(passive) is caused byMacrophage activation syndrome ( MAS
excessive activation and proliferation of T lymphocytes and macrophages(passive) to be caused byMacrophage activation syndrome ( MAS
refractory Kawasaki disease in an infant | BMJ Case Reports High - dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant(passive) caused bymacrophage activation syndrome
the activation and uncontrolled proliferation of T lymphocytes and macrophages(passive) to be caused byMacrophage activation syndrome ( MAS
hyperactivation of immune response as a consequence of impaired NK cells function(passive) is caused byMacrophage activation syndrome
hyperactivation of the macrophage immune response as a consequence of impaired natural killer cell function(passive) is caused byMacrophage activation syndrome
whose activating - mutations in humanscausemacrophage - activation syndrome
an imbalance in the regulation of cytokines and activation of T lymphocytes and macrophages with a significant increase of proinflammatory cytokinesmay triggera macrophage activation syndrome
certain infectious ( e.g. EBV(passive) is ... triggered byMacrophage activation syndrome ( MAS
viral infections(passive) to be triggered byMacrophage Activation Syndrome ( MAS
Neurological symptoms associated with renal or liver impairment , fever , lymphadenopathy and disseminated intravascular coagulationshould promptconsideration of macrophage activation syndrome
These inflammation phenotypescan leadto macrophage activation syndrome
PM / DM ... the diseasescausemacrophage activation syndrome ( MAS
iHPCs and that these cells also cause severe malarial anemia(passive) may be caused byMacrophage Activation Syndrome
an interesting case who presented with prolonged fever , native valve endocarditis and infectiontriggeredMacrophage activation syndrome
a bladder infection(passive) caused byMacrophage Activation Syndrome
herpes viral infection as the presenting manifestation of juvenile systemic lupus erythematosus , ” Pediatric Infection and Vaccine(passive) triggered byMacrophage activation syndrome
Herpes Viral Infection as the Presenting Manifestation of Juvenile Systemic Lupus Erythematosus Noh , Ji Hye(passive) Triggered byMacrophage Activation Syndrome
from uncontrolled activation and proliferation of T lymphocytes and macrophagesresultingfrom uncontrolled activation and proliferation of T lymphocytes and macrophages
low levels of blood cells and factors that are important for forming blood clotscauseslow levels of blood cells and factors that are important for forming blood clots
from NLRC4 mutation - associated elevation of IL-18 drives our enthusiasm for this agent and the innovative methodologies that continue to guide the clinical development processresultingfrom NLRC4 mutation - associated elevation of IL-18 drives our enthusiasm for this agent and the innovative methodologies that continue to guide the clinical development process
to fatality in subcutaneous panniculitis - like T cell lymphomaleadingto fatality in subcutaneous panniculitis - like T cell lymphoma
to decreased cytolytic function of lymphocytesleadto decreased cytolytic function of lymphocytes